Outcome measures for children with mitochondrial disease: consensus recommendations for future studies from a Delphi-based international workshop

Journal of Inherited Metabolic Disease
Saskia KoeneJan A M Smeitink

Abstract

Although there are no effective disease-modifying therapies for mitochondrial diseases, an increasing number of trials are being conducted in this rare disease group. The use of sensitive and valid endpoints is essential to test the effectiveness of potential treatments. There is no consensus on which outcome measures to use in children with mitochondrial disease. The aims of this two-day Delphi-based workshop were to (i) define the protocol for an international, multi-centre natural history study in children with mitochondrial myopathy and (ii) to select appropriate outcome measures for a validation study in children with mitochondrial encephalopathy. We suggest two sets of outcome measures for a natural history study in children with mitochondrial myopathy and for a proposed validation study in children with mitochondrial encephalopathy.

References

Feb 16, 2000·Lancet·J V Leonard, A H Schapira
Oct 2, 2001·American Journal of Medical Genetics·P F Chinnery, D M Turnbull
Nov 7, 2003·Clinical Pediatrics·D SkladalW Sperl
Apr 4, 2007·Pediatrics·François-Guillaume DebrayGrant A Mitchell
Sep 22, 2007·Annals of Neurology·Andrew M SchaeferDouglass M Turnbull
Aug 12, 2008·Journal of Affective Disorders·S KoeneE Morava
Mar 10, 2012·Journal of Inherited Metabolic Disease·Paul de LaatJan A M Smeitink
May 12, 2012·Archives of Physical Medicine and Rehabilitation·Amanda F CaseyKristin Osterling
Mar 16, 2013·Developmental Medicine and Child Neurology·Saskia KoeneJan A M Smeitink
Jul 3, 2013·Nature Reviews. Neurology·Gerald PfefferPatrick F Chinnery
Aug 25, 2015·The Australian and New Zealand Journal of Psychiatry·Anthony F Jorm
Mar 10, 2016·EMBO Molecular Medicine·Werner Jh KoopmanJan Am Smeitink
Oct 25, 2016·Nature Reviews. Disease Primers·Gráinne S GormanDouglass M Turnbull
Dec 3, 2016·Biochemical Society Transactions·Carlo Viscomi
Oct 28, 2017·Neuromuscular Disorders : NMD·Michelangelo MancusoUNKNOWN consortium on Trial Readiness in Mitochondrial Myopathies
Feb 10, 2018·American Journal of Medical Genetics. Part a·Gerald F Cox
Jun 16, 2018·Lancet·Joyeeta Rahman, Shamima Rahman
Jul 8, 2018·Essays in Biochemistry·Nandaki Keshavan, Shamima Rahman

❮ Previous
Next ❯

Citations

Jul 4, 2020·Journal of Inherited Metabolic Disease·Robert D S PitceathlyShamima Rahman
Jul 29, 2020·Journal of Human Genetics·Naoyuki Kamatani
Mar 30, 2020·Cell·Oliver M RussellDoug M Turnbull
Oct 31, 2021·Annals of Neurology·Albert Z LimRobert McFarland
Feb 6, 2022·The Laryngoscope·Richard Paul BoeschUNKNOWN Aerodigestive Research Collaborative

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Nihon rinsho. Japanese journal of clinical medicine
T Muro
American Journal of Clinical Pathology
E R Fisher, T S Danowski
Deutsche medizinische Wochenschrift
H Reichmann
F1000 Medicine Reports
Bridget A Bagert, Dennis Bourdette
© 2022 Meta ULC. All rights reserved